Insmed Incorporated Insmed Incorporated

Insmed Incorporated

INSM

Rang in aandelen #1111
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Aandeelprijs
$95.88
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$20.94B
Verandering (1 dag)
0.61%
Verandering (1 jaar)
-42.00%
Land
US
Handel Insmed Incorporated (INSM)

Categorie

Healthcare
Aandelsplitsingen voor Insmed Incorporated (INSM)
Het aandeel Insmed Incorporated (symbool: INSM) heeft in totaal 2 splitsingen ondergaan.
De meest recente splitsing vond plaats op Mar 03, 2011.
Eén aandeel INSM dat vóór Jul 31, 2000 werd gekocht, staat nu gelijk aan 0.025 aandelen INSM.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2011-03-03 1:10 x0.1 x0.025
2000-07-31 1:4 x0.25 x0.25
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL